True North
People
Kedaara Capital ropes in former executive from True North
Private equity firm Kedaara Capital, which had raised India’s largest sector-agnostic PE fund earlier this year and has made a ......
Healthcare
Bottomline: PE-backed Integrace's margins shrink, revenue growth marginally better
Drugmaker Integrace Pvt Ltd, which has Indian private equity firm True North and Singapore state investment firm Temasek on its cap ......
Finance
Temasek, A91 double down on Niva Bupa Health Insurance as IPO opens
Singapore state investment firm Temasek and Indian mid-market private equity firm A91 Partners have doubled down on their earlier bets ......
Finance
True North to score spectacular returns from financial services bet
Homegrown private equity firm True North has managed to strike the right notes with a financial services company that it ......
Consumer
True North virtually writes off investment in consumer firm
Private equity firm True North, which has made several monetisation moves this year and last while also slashing the target ......
Finance
Creador, True North's exit plans move ahead as portfolio companies get IPO nod
Private equity firms True North and Creador’s separate plans to monetize their investments are moving forward with two of their ......
Finance
ChrysCap hits the road to raise biggest PE fund ever in India
Homegrown private equity firm ChrysCapital has launched its tenth fund, which may turn out to be the largest PE fund ever ......
General
Grapevine: True North plans an exit; Edelweiss Alts, CarDekho, Afcons in IPO news
Private equity firm True North is considering a complete exit from Shree Digvijay Cement Company, where it holds a 54.83% ......
Finance
True North hires former Investec exec for private credit vertical
Mumbai-based True North, a homegrown private equity firm which wrapped up fundraising for its maiden private credit fund earlier this ......
Healthcare
Exclusive: Biocon weighs fresh funding for PE-backed biosimilars unit
Biocon Ltd is looking to raise fresh funding for its biosimilars unit that has previously secured capital from five private ......